To Identify Potential New Urine Marker Panel for Cancer Screening
Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers.
| Condition(s) | Cancer |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | Polyamines are naturally produced metabolites in our cells. There were some reports suggested the urinary levels of polyamines were altered in patients with different cancers. This study is to explore the use of urinary polyamine for the diagnosis of common cancers. |
| Who can participate | Inclusion Criteria: 1. Adult patients with age \> 18 years old. 2. For cancer patients, a histological diagnosis of cancer is available. 3. For normal control, there is no diagnosis of cancer in the medical record. Exclusion Criteria: 1. Patient with recent urinary tract infection within 6 weeks prior to urine collection. 2. Patient with recent urethral instrumentation, such as Foley catheter insertion, cystoscopy etc, within 6 weeks prior to urine collection. 3. Patient refused or unable to provide consent for the study |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | Chinese University of Hong Kong |
| Locations | Shatin, Hong Kong |
| Start date | 2021-01-20 |
| NCT ID | NCT04689802 |
| Official listing | https://clinicaltrials.gov/study/NCT04689802 |